Back to stocks
AURA

AURA

Aura Biosciences, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
22
Partial Q3 2026
Total 13F value
$1.5M
Filed positions so far
New positions
3
This quarter
Sold positions
1
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Y-Intercept (Hong Kong) Ltd

$1.1M174.1K0.02%New Position

China Universal Asset Management Co., Ltd.

$183K29.7K0.01%+21.1%

Wealth Enhancement Advisory Services, Llc

$124K19.1K0.00%+6.6%

Vontobel Holding Ltd.

$69K11.0K0.00%Unchanged

Nisa Investment Advisors, Llc

$16K2.5K0.00%Unchanged

Gf Fund Management Co. Ltd.

$14K2.2K0.00%+8.8%

Sterling Capital Management Llc

$12K1.9K0.00%+809.8%

Versant Capital Management, Inc

$10K1.5K0.00%+49.3%

Gamma Investing Llc

$7K1.1K0.00%+7.0%

Signaturefd, Llc

$2K3650.00%Unchanged

Parkside Financial Bank & Trust

$2K2450.00%+45.0%

Financial Consulate, Inc

$1K2300.00%New Position

Ifp Advisors, Inc

$1K1920.00%-8.1%

Blue Trust, Inc.

$540860.00%Unchanged

Root Financial Partners, Llc

$509810.00%New Position

Massmutual Private Wealth & Trust, Fsb

$490780.00%Unchanged

True Wealth Design, Llc

$465740.00%-14.9%

Essential Partners Llc

$446710.00%-38.8%

Sbi Securities Co., Ltd.

$214340.00%Unchanged

Farther Finance Advisors, Llc

$214340.00%-92.2%

Inspire Investing, Llc

$3450.00%Unchanged

Sjs Investment Consulting Inc.

$1320.00%-98.5%

Explore